Magazine Article | March 1, 2023

A Recipe For Start-Up Success With A Platform Technology

Source: Life Science Leader

By Neela Patel and John Mulligan

Startup and privately held biotechnology companies with a broadly applicable technology face a market that awards higher valuations to assets than to platforms for drug discovery. Platform companies, therefore, face a fundamental problem — how to return money to investors in a reasonable time frame and simultaneously realize the appropriate value for their platform.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader